Drugs / Agriflu
last change Jun 2022 re-read 2 minutes ago

Agriflu

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · Novartis · Novartis Vaccines · Roswell Park Cancer Institute

Trials 3 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04484532 Oct 2017 → Jun 2022 acute myeloid leukemia, myelodysplastic syndrome Roswell Park Cancer Institute Completed No outcome recorded
Phase 21 trial
Phase 2 NCT01173211 Sep 2010 → Nov 2011 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 41 trial
Phase 4 NCT01867021 May → Dec 2013 influenza Novartis Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT01248208 Comparator Sep 2010 → Sep 2011 food allergy Walter Reed Army Medical Center Completed No outcome recorded
Phase 41 trial
Phase 4 NCT01368796 Comparator Jul → Dec 2011 University of British Columbia Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Agriflu “Study subjects will be randomized 1:1:1 to receive one of the following three 2010-2011 seasonal inactivated trivalent influenza vaccines: Fluarix®, Agriflu®, or Fluzone® (60...” NCT01173211
4

Agriflu (age 18y and older)” NCT01248208

AgrifluNCT04484532

NCT01867021

NCT01368796

Modality Vaccine “The seasonal vaccine (Agriflu, Novartis) contains egg-derived, inactivated and detergent split versions of the 3 influenza strains (tri-valent).” NCT01368796
Route Intramuscular “It is given into the muscle of the upper arm at a dose of 0.5 mL.” NCT01368796